Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab versus placebo in Sjögren's syndrome
2007-003166-18Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in Sjögren's syndrome, sponsored by Centre Hospitalier Universitaire de Brest. Started Jun 2007; status: completed.
02
Drugs
rituximab
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on 2007-003166-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003166-18.